Cryo Global Registry

NCT02752737 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5385

Last updated 2025-07-30

No results posted yet for this study

Summary

Cryo Global Registry a prospective, global, multi-center, observational Post-Market Registry

Conditions

Sponsors & Collaborators

  • Medtronic Cardiac Ablation Solutions

    lead INDUSTRY

Principal Investigators

  • Khaldoun Tarakji, MD · Medtronic CAS Chief Medical Officer

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-02
Primary Completion
2024-11-29
Completion
2024-11-29

Countries

  • United States
  • Argentina
  • Austria
  • Belgium
  • Brunei
  • Chile
  • China
  • Colombia
  • Czechia
  • Germany
  • Greece
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Italy
  • Japan
  • Kazakhstan
  • Kuwait
  • Malaysia
  • Mexico
  • Oman
  • Philippines
  • Poland
  • Portugal
  • Russia
  • Saudi Arabia
  • Serbia
  • Singapore
  • Slovakia
  • South Africa
  • South Korea
  • Spain
  • Switzerland
  • Taiwan
  • Thailand
  • United Arab Emirates
  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02752737 on ClinicalTrials.gov